Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C27H31Cl2N3O6S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

253153-07-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 253153-07-0 Structure
  • Basic information

    1. Product Name: C27H31Cl2N3O6S
    2. Synonyms: C27H31Cl2N3O6S
    3. CAS NO:253153-07-0
    4. Molecular Formula:
    5. Molecular Weight: 596.532
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 253153-07-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C27H31Cl2N3O6S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C27H31Cl2N3O6S(253153-07-0)
    11. EPA Substance Registry System: C27H31Cl2N3O6S(253153-07-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 253153-07-0(Hazardous Substances Data)

253153-07-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 253153-07-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,1,5 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 253153-07:
(8*2)+(7*5)+(6*3)+(5*1)+(4*5)+(3*3)+(2*0)+(1*7)=110
110 % 10 = 0
So 253153-07-0 is a valid CAS Registry Number.

253153-07-0Relevant articles and documents

Inhibitors of α4β1 mediated cell adhesion

-

Page/Page column 105, (2010/02/05)

The present invention relates to compound of formula (I), that are potent inhibitors of α4β1mediated adhesion to either VCAM or CS-1 and which could be useful for the treatment of inflammatory diseases. Specifically, the molecules of the present invention can be used for treating or preventing α4β1adhesion mediated conditions in a mammal such as a human. This method may comprise administering to a mammal or a human patient an effective amount of the compound or composition as explained in the present specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 253153-07-0